Skip to main content

Anavex Life Sciences Corp.

AVXL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001314052

No open-market purchases or sales by Anavex Life Sciences Corp. insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $95.8M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Anavex Life Sciences Corp. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of AVXL: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders1392150+13
Shares25.1M26.2K24.9M−124.0K (−0.5%)
Value$308.2M$322.0K$249.4M−$58.5M (−19.0%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Anavex Life Sciences Corp. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to AVXL in Q2 2022
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC357,800$3.58M0.00%
Millennium Management LLC261,292$2.62M0.00%
Qube Research & Technologies Ltd64,094$642.0K0.00%
HRT Financial LP44,822$448.0K0.00%
SG Americas Securities, LLC33,494$335.0K0.00%
Trexquant Investment LP30,021$301.0K0.01%
Walleye Trading LLC28,680$287.0K0.01%
Mirae Asset Global Investments Co., Ltd.20,997$210.0K0.00%
Connor, Clark & Lunn Investment Management Ltd.16,922$169.0K0.00%
Schonfeld Strategic Advisors LLC16,799$168.0K0.00%
Wolverine Trading, LLC15,875$157.0K0.00%
Gotham Asset Management, LLC14,417$144.0K0.00%
Alpine Global Management, LLC10,770$108.0K0.03%
Quantbot Technologies LP6,398$64.0K0.01%
SeaCrest Wealth Management, LLC4,375$44.0K0.01%
Jefferies Group LLC3,403$34.1K0.00%
Lazard Asset Management LLC2,645$26.0K0.00%
Vectors Research Management, LLC2,000$20.0K0.01%
Trust Co of Vermont300$3.00K0.00%
Hoey Investments, Inc300$3.00K0.00%
Total Clarity Wealth Management, Inc.250$3.00K0.00%
US Bancorp164$2.00K0.00%
Harbour Investments, Inc.200$2.00K0.00%
Bangor Savings Bank150$2.00K0.00%
Investors Asset Management of Georgia Inc100$1.00K0.00%
Eagle Bay Advisors LLC50$5010.00%
Glassman Wealth Services23$00.00%

Sold out (14)

Institutions that held Anavex Life Sciences Corp. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of AVXL in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Knoll Capital Management, LLC210,789$2.60M
Prudential Financial Inc97,780$1.20M
Twinbeech Capital LP47,909$590.0K
Engineers Gate Manager LP22,491$277.0K
Liberty One Investment Management, LLC13,119$161.0K
Point72 Hong Kong Ltd4,063$50.0K
Cutler Group LP1,709$21.0K
Bedel Financial Consulting, Inc.1,210$15.0K
Aquatic Capital Management LLC1,200$15.0K
Harbor Investment Advisory, LLC1,000$12.0K
Dravo Bay LLC300$3.69K
Ellevest, Inc.25$0
Parallel Advisors, LLC17$0
Aaron Wealth Advisors21,517–

Not filed for Q2 2022 yet (2)

Institutions that held Anavex Life Sciences Corp. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AVXL in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Parametric Portfolio Associates LLC15,293$188.0K
Amalgamated Financial Corp.10,923$134.0K